Evidence map›Paper›PMID 27206917›Full record

ArticleDrugs2016

Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

Philippe Moreau, Niels W C J van de Donk, Jesus San Miguel, Henk Lokhorst, Hareth Nahi, Dina Ben-Yehuda, Michele Cavo, Gordon Cook, Michel Delforge, Hermann Einsele and 10 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Philippe MoreauHematology Department, University Hospital Hôtel-Dieu, Place Ricordeau, 44093, Nantes, France. philippe.moreau@chu-nantes.fr.
Niels W C J van de DonkVU University Medical Center, Amsterdam, The Netherlands.
Jesus San MiguelUniversity Hospital Navarra, Pamplona, Spain.
Henk LokhorstVU University Medical Center, Amsterdam, The Netherlands.
Hareth NahiKarolinska University Hospital Huddinge, Stockholm, Sweden.
Dina Ben-YehudaHadassah Medical Center, Jerusalem, Israel.
Michele CavoUniversity School of Medicine, Bologna, Italy.
Gordon CookSt James's University Hospital, Leeds, UK.
Michel DelforgeCatholic University of Leuven, Leuven, Belgium.
Hermann EinseleJulius Maximilian University, Würzburg, Germany.
Sonja ZweegmanVU University Medical Center, Amsterdam, The Netherlands.
Heinz LudwigWilhelminen hospital, Vienna, Austria.
Christoph DriessenKantonsspital St. Gallen, St. Gallen, Switzerland.
Antonio PalumboUniversity of Torino, Torino, Italy.
Thierry FaconUniversity Hospital Lille, Lille, France.
Torben PlesnerVejle Hospital and University of Southern Denmark, Vejle, Denmark.
Meletios DimopoulosUniversity Athens School of Medicine, Athens, Greece.
Pia SondergeldUniversity of Giessen, Giessen, Germany.
Pieter SonneveldErasmus MC Cancer Insitute, Rotterdam, The Netherlands.
María-Victoria MateosUniversity Hospital of Salamanca, Salamanca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27206917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.